Sclerostin monoclonal antibody therapy — the Wnt signaling pathway inhibition promoting osteoblast-mediated bone formation representing the fastest-growing anabolic segment in the global bone and...
Depressive disorders continue to represent a significant healthcare challenge across North America, with increasing prevalence rates influencing treatment demand, healthcare spending, and pharmac...
The global landscape for autism spectrum disorder treatment and support services is evolving steadily as healthcare systems, caregivers, and policymakers focus more intensely on neurodevelopmenta...
Pharmaceutical companies are investing heavily in research and development for epilepsy therapies. The introduction of innovative drugs is expanding treatment options for patients. These efforts ar...
Anxiety disorders and depression continue to represent some of the most prevalent and disabling mental health conditions worldwide. As awareness increases and demand for effective care grows, tre...
